Paul D. Burgess - 20 Jun 2023 Form 3 Insider Report for Cerevel Therapeutics Holdings, Inc.

Role: Title: Chief Business Development and Strategic Operations Officer. Exhibit 24 - Power of Attorney
Signature: /s/ Mark Bodenrader, as Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 20 Jun 2023
Net transactions value: $0
Form type: 3
Filing time: 28 Jun 2023, 18:59:32 UTC
Previous filing: 14 Sep 2021
Next filing: 06 Jul 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Title: Chief Business Development and Strategic Operations Officer. Exhibit 24 - Power of Attorney